Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Introducing BPaL: Experiences from countries supported under the LIFT-TB project.
Journal: PloS one
Published: March 21, 2024
Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
Journal: The New England journal of medicine
Published: September 02, 2022
Male reproductive hormones in patients treated with pretomanid.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: June 02, 2022
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
Journal: BMJ open
Published: December 04, 2021
Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: May 29, 2021
Effect of Clofazimine Concentration on QT Prolongation in Patients Treated for Tuberculosis.
Journal: Antimicrobial agents and chemotherapy
Published: April 20, 2021
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: March 25, 2021
Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers.
Journal: Clinical pharmacology in drug development
Published: July 27, 2020
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. Reply.
Journal: The New England journal of medicine
Published: June 11, 2020
An Exposure-Response Perspective on the Clinical Dose of Pretomanid.
Journal: Antimicrobial agents and chemotherapy
Published: June 02, 2020
Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment".
Journal: Antimicrobial agents and chemotherapy
Published: May 06, 2020
Clofazimine pharmacokinetics in patients with TB: dosing implications.
Journal: The Journal of antimicrobial chemotherapy
Published: April 25, 2020
Last Updated: 09/26/2026